- CSL Behring
CSL Behring is a global leader in the
plasma protein biotherapeutic s industry, providing plasma-derived therapies and their recombinant analogs that treat rare and serious diseases.History
The company traces its roots back to
Emil von Behring , an innovator withserum therapies who won the firstNobel Prize in Physiology or Medicine . The company changed its name from ZLB Behring as part of its alignment with its parent organization, CSL Limited, a specialty biopharmaceutical company based in Melbourne, Australia.Products
CSL Behring manufactures and markets a range of plasma-derived and recombinant products and related services. The company's therapies are used in the
treatment ofimmune deficiency disorder s,hemophilia ,von Willebrand disease , other bleeding disorders and inheritedemphysema . Other products are used for the prevention of hemolytic disease in newborns, in cardiac surgery, organ transplantation and in the treatment of burns. The company also operates one of the world's largest plasma collection networks, ZLB Plasma.Offices
The company is headquartered in
King of Prussia, Pennsylvania . It has 7,000 employees in 19 countries. Major manufacturing centers are located inBern, Switzerland ,Marburg, Germany andKankakee, Illinois Finances
The company's sales in their fiscal year 2005/2006 were approximately U.S.$ 1.8 billion
External links
* [http://www.cslbehring.com/ Official Website]
* [http://nobelprize.org/nobel_prizes/medicine/laureates/1901/behring-bio.html Biography of Emil von Behring]
Wikimedia Foundation. 2010.
